Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Laboratory Corporation of America Holdings

27.3% sales growth and 10.9% return on equity

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide.

Laboratory Corporation of America Holdings sales growth this year is anticipated to be 15.7% and 4.3% for next year.

Year-on-year quarterly revenue growth grew by 33%, now sitting on 12.44B for the twelve trailing months.

Laboratory Corporation of America Holdings’s sales growth for the next quarter is 27.3%. The company’s growth estimates for the ongoing quarter and the next is 146.9% and 133.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.9%.

Laboratory Corporation of America Holdings’s Stock Top and Bottom Yearly Value

Laboratory Corporation of America Holdings’s stock is valued at $198.84 at 18:47 EST, below its 52-week high of $218.77 and way higher than its 52-week low of $98.02.

Laboratory Corporation of America Holdings’s Moving Average

Laboratory Corporation of America Holdings’s value is below its 50-day moving average of $202.24 and higher than its 200-day moving average of $186.28.

2. Medifast Inc

42.6% sales growth and 75.43% return on equity

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific.

MEDIFAST INC sales growth this year is anticipated to be 28.8% and 19.5% for next year.

Year-on-year quarterly revenue growth grew by 42.8%, now sitting on 840.56M for the twelve trailing months.

MEDIFAST INC’s sales growth for the next quarter is 42.6%. The company’s growth estimates for the present quarter and the next is 43.4% and 37.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 75.43%.

MEDIFAST INC’s Stock Top and Bottom Yearly Value

MEDIFAST INC’s stock is valued at $204.29 at 18:47 EST, below its 52-week high of $208.57 and way higher than its 52-week low of $49.03.

MEDIFAST INC’s Moving Average

MEDIFAST INC’s worth is way above its 50-day moving average of $166.65 and way above its 200-day moving average of $153.04.

3. Sapiens International Corporation N.V.

15.6% sales growth and 13.91% return on equity

Sapiens International Corporation N.V.

Sapiens International Corporation N.V. sales growth this year is anticipated to be 17.3% and 10.2% for next year.

Year-on-year quarterly revenue growth grew by 18.2%, now sitting on 367.96M for the twelve trailing months.

Sapiens International Corporation N.V.’s sales growth for the next quarter is 15.6%. The company’s growth estimates for the present quarter and the next is 19% and 20%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.91%.

Sapiens International Corporation N.V.’s Stock Top and Bottom Yearly Value

Sapiens International Corporation N.V.’s stock is valued at $29.89 at 18:47 EST, way under its 52-week high of $35.23 and way higher than its 52-week low of $13.55.

Sapiens International Corporation N.V.’s Moving Average

Sapiens International Corporation N.V.’s worth is higher than its 50-day moving average of $29.38 and above its 200-day moving average of $29.23.

4. Lam Research Corporation

28.4% sales growth and 50.4% return on equity

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits in the United States, China, Europe, Japan, Korea, Taiwan, and the southeast Asia.

Lam Research Corporation sales growth this year is anticipated to be 29% and 7% for next year.

Year-on-year quarterly revenue growth grew by 46.7%, now sitting on 11.06B for the twelve trailing months.

Lam Research Corporation’s sales growth for the next quarter is 28.4%. The company’s growth estimates for the ongoing quarter and the next is 41.1% and 35.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 50.4%.

Lam Research Corporation’s Stock Top and Bottom Yearly Value

Lam Research Corporation’s stock is valued at $446.78 at 18:47 EST, under its 52-week high of $451.12 and way above its 52-week low of $181.38.

Lam Research Corporation’s Moving Average

Lam Research Corporation’s worth is way higher than its 50-day moving average of $388.14 and way higher than its 200-day moving average of $340.50.

LEAVE A REPLY

Please enter your comment!
Please enter your name here